BioMarin Plans To Reduce Its Global Workforce By Approximately 225 Employees
BioMarin Plans To Reduce Its Global Workforce By Approximately 225 Employees
he Company decided to reduce its workforce in connection with organizational redesign efforts as well as the Company's updated strategy for ROCTAVIAN and its decision to discontinue development of BMN 293, as previously announced by BioMarin on August 5, 2024.
爲了ROCTAVIAN的最新策略以及終止BMN293的開發，公司決定在組織重設計劃中減少員工數量，正如BioMarin在2024年8月5日公告的那樣。
The Company estimates that it will incur aggregate pre-tax charges representing one-time cash expenditures for severance and other employee termination benefits of approximately $30 - $35 million, of which the majority is expected to be incurred during the second half of 2024.
公司估計將產生總計約3000-3500萬美元的稅前費用，用於一次性現金支出，用於支付離職費和其他員工解僱福利，其中大部分費用預計將在2024年下半年產生。
Impacted employees were notified by August 28, 2024, and workforce reductions are expected to be substantially completed by the end of 2024.
受影響的員工在2024年8月28日前收到通知，裁員工作預計將在2024年年底基本完成。